Rigel Pharmaceuticals reported $-19037000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agenus AGEN:US USD -56715000 7.48M
Anika Therapeutics ANIK:US USD -1912000 1.37M
Arrowhead Research ARWR:US USD -82157000 10.11M
AstraZeneca AZN:LN USD 3.09B 52M
Celldex Therapeutics CLDX:US USD -26784000 546K
Daiichi Sankyo 4568:JP JPY 61.85B 32.44B
Halozyme Therapeutics HALO:US USD 73.71M 21.78M
Heron Therapeutics HRTX:US USD -41882000 14.48M
Immunogen IMGN:US USD -77755000 15.73M
Intrexon XON:US USD -7694000 18.45M
Karyopharm Therapeutics KPTI:US USD -36279000 12.66M
Macrogenics MGNX:US USD -24813000 16.49M
Neurocrine Biosciences NBIX:US USD 97.9M 121.2M
Pfizer PFE:US USD 10.67B 3.11B
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Rigel Pharmaceuticals RIGL:US USD -19037000 5.54M
Sangamo Biosciences SGMO:US USD -53125000 10.03M
Ultragenyx Pharmaceutical RARE:US USD -238819000 80.96M
Veracyte VCYT:US USD -8875000 772K